+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Age Related Macular Degeneration"

From
From
From
From
From
From
From
From
From
From
Eyewear Market Report 2025 - Product Thumbnail Image

Eyewear Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Eye Health Supplements - Global Strategic Business Report - Product Thumbnail Image

Eye Health Supplements - Global Strategic Business Report

  • Report
  • March 2025
  • 246 Pages
  • Global
From
Spectacle Lens Market Report, Global, 2024 - Product Thumbnail Image

Spectacle Lens Market Report, Global, 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Macular Degeneration Treatment Market Report 2025 - Product Thumbnail Image

Macular Degeneration Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Eye Health Supplements Market Report 2025 - Product Thumbnail Image

Eye Health Supplements Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Retinal Biologics Market Report 2025 - Product Thumbnail Image

Retinal Biologics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness. Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD. Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more